Free Research Reports on ABMD, EBAY, PACW and TQNT Issued

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 19, 2013 at 8:17 PM

Free Research Reports on ABMD, EBAY, PACW and TQNT Issued by the Paragon Report

NEW YORK, NY--(Marketwired - Apr 18, 2013) - The Paragon Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

ABIOMED, Inc. ( NASDAQ : ABMD ) shares surged 8.63 percent on volume of 1.28 million shares traded Wednesday to close at $17.74 a share. The company reported preliminary revenues of $43.7 million for the fourth quarter of fiscal 2013, an increase of 17 percent when compared to the year ago quarter.

Find out more about ABIOMED including full access to the free equity report at: www.ParagonReport.com/ABMD

eBay Inc. ( NASDAQ : EBAY ) shares have gained approximately 10 percent year-to-date. The company in their recent earnings release forecasted a profit of $0.61 to $0.63 a share and revenue of $3.8 billion to $3.9 billion for the second quarter. According to Thomson Reuters I/B/E/S, analysts had expected earnings of $0.66 per share.

Find out more about eBay including full access to the free equity report at: www.ParagonReport.com/EBAY

PacWest Bancorp ( NASDAQ : PACW ) shares declined 2.46 percent on volume of over 900,000 shares traded Wednesday to close at $26.61 a share. The company reported net earnings were $13.5 million, or $0.37 per diluted share, for the first quarter of 2013, compared to net earnings of $19.9 million, or $0.54 per diluted share, in the previous quarter.

Find out more about PacWest Bancorp including full access to the free equity report at: www.ParagonReport.com/PACW

TriQuint Semiconductor ( NASDAQ : TQNT ) shares declined 3.23 percent on volume of 4.35 million shares traded Wednesday to close at $32.40 a share. Shares of Apple's chip suppliers were dragged down by a report from Cirrus Logic Inc. stating that revenues for the first quarter of 2013 have slowed, due to lower sales of a particular chip to a certain supplier.

Find out more about TriQuint Semiconductor including full access to the free equity report at: www.ParagonReport.com/TQNT

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information: Equity News Circuit Email Contact

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AAI Rolls Out Agency Gauge: AI-Driven Insights Platform

Bringing Artificial Intelligence to the Insurance Table Affordable American Insurance (AAI) is shaking things up in the insurance world with their new tool, Agency Gauge. Picture this: you're running an independent agency, neck-deep in data, and this AI-powered marvel swoops in and turns those confusing numbers into actionable business insights. It's like having a wise...

Faith and Resilience in China: The Legacy of the Long March

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

ASTS Faces a Legal Countdown – Investors Take Note

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

New Chapter Recovery Garners Key Accreditations

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

2GenPen & LordCap Team Up: Game-Changer in ABS?

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Lundbeck's Board Leadership Transitions into New Era

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Nomada Fund Launches: A Game-Changer in New Media

Changing the Investment Game In a world where tech isn't the only kingmaker, distribution is the new play. Welcome the Nomada Fund, a fresh face on the investment scene that's swapping cash for exposure. Forget the traditional media-for-equity model that only old-timers still drool over—these guys are taking it up a notch with their new Distribution for Equity approach,...

U.S. Millionaire Surge: Market Waves or Mirage?

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

AI-Designed Antivirals: A Brave New World

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...